|Bid||16.50 x N/A|
|Ask||17.50 x N/A|
|Day's range||16.12 - 17.50|
|52-week range||0.16 - 51.00|
|Beta (5Y monthly)||0.92|
|PE ratio (TTM)||N/A|
|Earnings date||11 Mar 2021 - 12 Mar 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
London-listed Kanabo has announced a deal to buy European operations of Materia in a major cannabis industry deal.
LONDON, July 26, 2021--Kanabo Group Plc (LSE:KNB) ("Kanabo" or the "Company"), the first medical cannabis company to IPO on London Stock Exchange, has signed a Letter of Intent to acquire Materia, a leading processor and distributor of medical cannabis and CBD wellness products across Europe.
CEO Avihu Tamir believes the product can replace opioids for pain management.